Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

psilocybe

$140.123M Market Capitalization Numinus Wellness Inc. (NUMI.T) announced today that it has formally submitted its clinical trial application (CTA) to Health Canada for its Phase 1 study, HOPE, on…
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which…
PsyBio Therapeutics (PSYB.V) announced it has filed a new provisional patent application with the US Patent and Trademark Office. The new patent is entitled Psilocybin and Norbaeocystin Compositions and…
Numinus Wellness (NUMI.V) partnered with KGK Science, a contract research organization focusing on natural products, for a few psilocybin extraction clinical trial today, according to a press release. The…
Numinus Wellness (NUMI.V) finished their first legal extraction of psilocybe mushrooms in Canada for research purposes today, according to a press release. This follows the company’s completion of their…